Latest On Catabasis Pharmaceuticals, Inc (CATB):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2021-08-10 00:51 EST | News | Catabasis Pharmaceuticals EPS misses by $0.59 | N/A |  |
| 2021-07-20 23:44 EST | News | CATB, XELB, CLSD and DTEA among after-hours movers | N/A | |
| 2021-07-20 23:43 EST | News | Catabasis Pharmaceuticals skyrockets 44% on 7.5% ownership disclosure by RA Capital | N/A | |
| 2021-07-20 23:32 EST | News | Catabasis Pharmaceuticals: Transformation Through Quellis Biosciences Acquisition | N/A | |
| 2021-03-16 20:23 EST | Analyst Rating | The Analyst Target Price has decreased from $14.5 to $5. | Neutral | |
| 2021-03-13 23:18 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-12 03:19 EST | Earnings Estimate | An EPS average of -$0.05 is estimated for the quarter ending on June 30, 2021. | Buy | |
| 2021-03-12 03:19 EST | Analyst Rating | The Analyst Target Price has decreased from $24 to $14.5. | Neutral | |
| 2021-03-12 03:19 EST | Earnings Estimate | An EPS average of -$0.39 is estimated for the 2022 year. | Buy | |
| 2021-03-12 01:01 EST | News | Catabasis Pharmaceuticals EPS misses by $0.20 | N/A | |
| 2021-02-17 18:38 EST | News | Can't Get My Head Around Catabasis Pharmaceuticals | N/A | |
| 2021-01-29 15:21 EST | News | Catabasis Pharma shares surge after Quellis Biosciences deal | N/A | |
| 2020-12-13 03:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-26 11:31 EST | Analyst Rating | The Analyst Target Price has increased from $12.57 to $24. | Buy | |
| 2020-11-15 11:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-14 03:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-13 11:30 EST | Earnings Estimate | An EPS average of -$0.30 is estimated for the quarter ending on March 31, 2021. | Buy | |
| 2020-11-12 19:32 EST | News | Catabasis Pharmaceuticals reports Q3 results | N/A | |
| 2020-11-03 11:18 EST | Analyst Rating | The Analyst Target Price has decreased from $33 to $12.57. | Neutral | |
| 2020-11-01 17:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-30 13:25 EST | News | Catabasis' Catastrophic Failure, And Other News: The Good, Bad And Ugly Of Biopharma | N/A | |
| 2020-10-27 16:38 EST | News | Catabasis -64% after halting development of edasalonexent | N/A | |
| 2020-10-16 16:23 EST | News | Catabasis Pharmaceuticals: Accumulating Ahead Of Edasalonexent's Top-Line Results | N/A | |
| 2020-10-03 00:22 EST | Analyst Rating | The Analyst Target Price has decreased from $37.5 to $33. | Neutral | |
| 2020-09-24 00:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-21 17:00 EST | News | Catabasis names Noah Clauser as CFO | N/A | |
| 2020-09-19 08:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-16 15:17 EST | News | Catabasis Pharmaceuticals Inc (CATB) Investor Presentation - Slideshow | N/A | |
| 2020-08-26 09:37 EST | News | Dyne Therapeutics on deck for IPO | N/A | |
| 2020-08-13 04:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-11 09:56 EST | News | Catabasis Pharmaceuticals EPS misses by $0.07 | N/A | |
| 2020-07-31 00:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 16:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-10 08:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 08:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-29 19:24 EST | News | Catabasis joins Russell 3000 index | N/A | |
| 2020-06-13 15:14 EST | News | Catabasis Pharmaceuticals names Ben Harshbarger as Senior VP, General Counsel | N/A | |
| 2020-06-02 08:18 EST | Earnings Estimate | An EPS average of -$0.44 is estimated for the quarter ending on September 30, 2020. | Buy | |
| 2020-05-31 16:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-15 20:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-13 01:50 EST | News | Catabasis Pharmaceuticals EPS misses by $0.09 | N/A | |
| 2020-05-03 08:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-11 06:43 EST | News | Key events next week - healthcare | N/A | |
| 2020-04-11 06:28 EST | News | Catabasis Pharmaceuticals EPS beats by $0.07 | N/A | |
| 2020-04-07 00:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-25 04:08 EST | News | Catabasis: Worth A Look Ahead Of Phase III Data | N/A | |
| 2020-03-13 00:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-11 12:08 EST | News | Catabasis Pharmaceuticals Inc. (CATB) CEO Jill Milne on Q4 2019 Results - Earnings Call Transcript | N/A | |
| 2020-03-11 04:17 EST | Analyst Rating | The Analyst Target Price has decreased from $39 to $37.5. | Neutral | |
| 2020-03-11 04:17 EST | Earnings Estimate | An EPS average of -$0.12 is estimated for the 2021 year. | Buy | |
About Catabasis Pharmaceuticals, Inc (CATB):
Catabasis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics in the United States. The company's lead product candidate is QLS-215, a monoclonal antibody inhibitor of plasma kallikrein that is in preclinical development for the treatment of hereditary angioedema, a rare, debilitating and potentially life-threatening disease. The company was incorporated in 2008 and is based in Boston, Massachusetts.
General
- Name Catabasis Pharmaceuticals, Inc
- Symbol CATB
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 20
- Last Split Factor1:10
- Last Split Date2018-12-31
- Fiscal Year EndDecember
- IPO Date2015-06-25
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.catabasis.com
View More
Valuation
- Price/Book (Most Recent Quarter) 2.06
- Enterprise Value EBITDA 0.12
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.66
- Next Year EPS Estimate -$0.64
- Return on Assets -52%
- Return on Equity -98%
- Earnings Per Share -$2.81
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 78.68 million
- EBITDA -24826000
- Analyst Target Price $5
- Book Value Per Share $2.03
View More
Share Statistics
- Shares Outstanding 23.42 million
- Shares Float 20.37 million
- % Held by Insiders 13%
- % Held by Institutions 40.64%
- Shares Short 2.58 million
- Shares Short Prior Month 2.39 million
- Short Ratio 0.17
- Short % of Float 13%
- Short % of Shares Outstanding 11%
View More
Technicals
- Beta 1.88
- 52 Week High $8.59
- 52 Week Low $1.25
- 50 Day Moving Average 3.25
- 200 Day Moving Average 3.55
View More
Dividends
- Dividend Date 2018-12-31
- ExDividend Date N/A
- Dividend Yield 0%
View More
Catabasis Pharmaceuticals, Inc (CATB) Dividend Calendar:
CATB's last dividend payment was made to shareholders on December 31, 2018.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Catabasis Pharmaceuticals, Inc (CATB) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-11 | $N/A | -$0.44 | -$0.34 | -29.41% |
| 2020-09-30 | 2020-11-12 | $N/A | -$0.56 | -$0.51 | -9.8% |
| 2020-06-30 | 2020-08-10 | $N/A | -$0.53 | -$0.46 | -16.48% |
| 2020-03-31 | 2020-05-12 | $N/A | -$0.50 | -$0.41 | -21.95% |
| 2019-12-31 | 2020-03-10 | $N/A | -$0.55 | -$0.62 | 10.57% |
| 2019-09-30 | 2019-11-07 | $N/A | -$0.56 | -$0.64 | 11.99% |
| 2019-06-30 | 2019-08-08 | $N/A | -$0.62 | -$0.61 | -2.21% |
| 2019-03-31 | 2019-05-14 | $N/A | -$0.62 | -$0.70 | 10.79% |
| 2018-12-31 | 2019-03-14 | $N/A | -$0.85 | -$0.90 | 5.87% |
| 2018-09-30 | 2018-11-13 | $N/A | -$0.80 | -$1.35 | 40.66% |
| 2018-06-30 | 2018-08-09 | $N/A | -$2.00 | -$2.65 | 24.53% |
| 2018-03-31 | 2018-05-10 | $N/A | -$2.90 | -$2.25 | -28.89% |
| 2017-12-31 | 2018-03-15 | $250000 | -$2.40 | -$3.05 | 21.31% |
| 2017-09-30 | 2017-11-09 | $250000 | -$3.10 | -$3.27 | 5.1% |
| 2017-06-30 | 2017-08-10 | $N/A | -$3.20 | -$3.90 | 17.95% |
| 2017-03-31 | 2017-05-11 | $N/A | -$4.10 | -$4.53 | 9.56% |
| 2016-12-31 | 2017-03-16 | $N/A | -$4.70 | -$4.88 | 3.59% |
| 2016-09-30 | 2016-11-10 | $N/A | -$5.40 | -$6.47 | 16.5% |
| 2016-06-30 | 2016-08-11 | $N/A | -$6.10 | -$6.40 | 4.69% |
| 2016-03-31 | 2016-05-12 | $N/A | -$6.10 | -$6.40 | 4.69% |
| 2015-12-31 | 2016-03-02 | $N/A | -$6.30 | -$7.13 | 11.68% |
| 2015-09-30 | 2015-11-12 | $N/A | -$0.55 | -$0.64 | 14.06% |
| 2015-06-30 | 2015-08-13 | $N/A | -$8.07 | -$0.71 | -1036.62% |
Catabasis Pharmaceuticals, Inc (CATB) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | 5.29 million | 4.13 million |
| Income Before Tax | N/A | N/A | N/A | -7.95 million | -6.61 million |
| Selling General Administrative | N/A | N/A | N/A | 2.75 million | 2.62 million |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Ebit | N/A | N/A | N/A | -8.04 million | -6.75 million |
| Operating Income | N/A | N/A | N/A | -8.04 million | -6.75 million |
| Income Tax Expense | N/A | N/A | N/A | N/A | N/A |
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A |
| Total Other Income Expense Net | N/A | N/A | N/A | -77000 | 137000 |
| Net Income From Continuing Operations | N/A | N/A | N/A | -7.95 million | -6.61 million |
| Net Income Applicable to Common Shares | -8.98 million | -10.86 million | -9.51 million | N/A | -6.61 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | -15.43 million | -3.49 million | 13.65 million |
| Change to Liabilities | 237000 | 475000 | N/A | -893000 | 842000 |
| Total Cash Flow from Investing Activities | 2 million | 39.74 million | N/A | -3.5 million | 13.65 million |
| Net Borrowings | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | N/A | N/A | 25.62 million | 3.77 million | 973000 |
| Change to Operating Activities | 262000 | 1.19 million | N/A | -584000 | -1.19 million |
| Change in Cash | N/A | N/A | 3.2 million | -7.5 million | 8.15 million |
| Total Cash from Operating Activities | -9.97 million | -7.47 million | -6.99 million | -7.77 million | -6.47 million |
| Depreciation | N/A | N/A | N/A | 3000 | 8000 |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Net Income | 394000 | 382000 | N/A | 314000 | 380000 |
| Capital Expenditures | N/A | N/A | N/A | 12000 | N/A |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | N/A | 5.47 million | 6.06 million |
| Total Stockholder Equity | N/A | N/A | N/A | 53.71 million | 35.72 million |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A | 59.18 million | 41.78 million |
| Common Stock | 20000 | 20000 | 19000 | N/A | 12000 |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | -260.9 million | -251.92 million | -241.06 million | -231.55 million | -223.6 million |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A |
| Other Assets | 165000 | 160000 | 163000 | N/A | 473000 |
| Cash | N/A | N/A | N/A | 13.34 million | 9.9 million |
| Total Current Liabilities | 6.39 million | 6.98 million | N/A | 4.59 million | 5.03 million |
| Other Stockholder Equity | N/A | N/A | 1000 | N/A | N/A |
| Property, Plant & Equipment | 966000 | 1.18 million | 1.33 million | N/A | 2.35 million |
| Total Current Assets | 46.33 million | 55.51 million | N/A | 57.14 million | 38.96 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 40.67 million | 49.31 million | 50.86 million | N/A | 35.72 million |
| Short Term Investments | N/A | N/A | N/A | 41.76 million | 26.35 million |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | 1.54 million | 1.41 million | N/A | 709000 | 1.2 million |
Catabasis Pharmaceuticals, Inc (CATB) Chart:
Catabasis Pharmaceuticals, Inc (CATB) News:
Below you will find a list of latest news for Catabasis Pharmaceuticals, Inc (CATB) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Catabasis Pharmaceuticals, Inc (CATB) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Catabasis Pharmaceuticals, Inc (CATB) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000110465920072749/0001104659-20-072749-index.htm |
| 2018-06-12 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1454789/000000000018017932/0000000000-18-017932-index.htm |
| 2019-05-21 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1454789/000000000019008747/0000000000-19-008747-index.htm |
| 2018-06-25 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1454789/000090266418002661/0000902664-18-002661-index.htm |
| 2019-01-17 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1454789/000090266419000273/0000902664-19-000273-index.htm |
| 2018-07-02 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1454789/000091957418004481/0000919574-18-004481-index.htm |
| 2019-02-19 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1454789/000091957419001878/0000919574-19-001878-index.htm |
| 2018-06-28 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1454789/000093583618000365/0000935836-18-000365-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1454789/000093583619000104/0000935836-19-000104-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1454789/000093583620000110/0000935836-20-000110-index.htm |
| 2018-06-12 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1454789/000104746918004419/0001047469-18-004419-index.htm |
| 2018-06-15 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1454789/000104746918004492/0001047469-18-004492-index.htm |
| 2018-06-18 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1454789/000104746918004538/0001047469-18-004538-index.htm |
| 2018-06-20 | S-1MEF | Registration adding securities to prior Form S-1 registration [Rule 462(b)] | https://www.sec.gov/Archives/edgar/data/1454789/000104746918004590/0001047469-18-004590-index.htm |
| 2018-06-20 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1454789/000104746918004625/0001047469-18-004625-index.htm |
| 2018-10-12 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1454789/000104746918006698/0001047469-18-006698-index.htm |
| 2018-10-23 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1454789/000104746918006826/0001047469-18-006826-index.htm |
| 2018-11-13 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1454789/000104746918007191/0001047469-18-007191-index.htm |
| 2019-02-05 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1454789/000104746919000358/0001047469-19-000358-index.htm |
| 2019-02-06 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1454789/000104746919000374/0001047469-19-000374-index.htm |
| 2019-03-14 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1454789/000104746919001212/0001047469-19-001212-index.htm |
| 2019-04-22 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1454789/000104746919002458/0001047469-19-002458-index.htm |
| 2019-05-14 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1454789/000104746919003078/0001047469-19-003078-index.htm |
| 2019-05-14 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1454789/000104746919003079/0001047469-19-003079-index.htm |
| 2019-05-22 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1454789/000104746919003254/0001047469-19-003254-index.htm |
| 2019-05-23 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1454789/000104746919003278/0001047469-19-003278-index.htm |
| 2019-05-23 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1454789/000104746919003279/0001047469-19-003279-index.htm |
| 2019-05-23 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1454789/000104746919003280/0001047469-19-003280-index.htm |
| 2020-01-29 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1454789/000104746920000582/0001047469-20-000582-index.htm |
| 2020-01-30 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1454789/000104746920000612/0001047469-20-000612-index.htm |
| 2020-03-10 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1454789/000104746920001338/0001047469-20-001338-index.htm |
| 2020-04-28 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1454789/000104746920002643/0001047469-20-002643-index.htm |
| 2018-06-19 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1454789/000110465918040968/0001104659-18-040968-index.htm |
| 2018-06-19 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1454789/000110465918040969/0001104659-18-040969-index.htm |
| 2018-06-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1454789/000110465918041160/0001104659-18-041160-index.htm |
| 2018-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1454789/000110465918050776/0001104659-18-050776-index.htm |
| 2018-10-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1454789/000110465918062289/0001104659-18-062289-index.htm |
| 2018-11-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1454789/000110465918067718/0001104659-18-067718-index.htm |
| 2018-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1454789/000110465918067755/0001104659-18-067755-index.htm |
| 2018-11-13 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1454789/000110465918067758/0001104659-18-067758-index.htm |
| 2018-12-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1454789/000110465918072953/0001104659-18-072953-index.htm |
| 2018-12-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1454789/000110465918075355/0001104659-18-075355-index.htm |
| 2018-12-31 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1454789/000110465918075356/0001104659-18-075356-index.htm |
| 2019-01-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1454789/000110465919001374/0001104659-19-001374-index.htm |
| 2019-02-05 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1454789/000110465919005823/0001104659-19-005823-index.htm |
| 2019-02-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1454789/000110465919006087/0001104659-19-006087-index.htm |
| 2019-02-06 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1454789/000110465919006093/0001104659-19-006093-index.htm |
| 2019-02-13 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1454789/000110465919007909/0001104659-19-007909-index.htm |
| 2019-02-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1454789/000110465919008694/0001104659-19-008694-index.htm |
| 2019-04-22 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1454789/000110465919022873/0001104659-19-022873-index.htm |
| 2019-05-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1454789/000110465919029116/0001104659-19-029116-index.htm |
| 2019-05-21 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1454789/000110465919030801/0001104659-19-030801-index.htm |
| 2019-06-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1454789/000110465919034023/0001104659-19-034023-index.htm |
| 2019-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1454789/000110465919042921/0001104659-19-042921-index.htm |
| 2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1454789/000110465919044710/0001104659-19-044710-index.htm |
| 2019-09-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1454789/000110465919050067/0001104659-19-050067-index.htm |
| 2019-09-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1454789/000110465919051019/0001104659-19-051019-index.htm |
| 2019-10-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1454789/000110465919054384/0001104659-19-054384-index.htm |
| 2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1454789/000110465919060826/0001104659-19-060826-index.htm |
| 2019-12-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1454789/000110465919074075/0001104659-19-074075-index.htm |
| 2019-12-19 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000110465919074077/0001104659-19-074077-index.htm |
| 2020-01-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1454789/000110465920008669/0001104659-20-008669-index.htm |
| 2020-04-28 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1454789/000110465920052392/0001104659-20-052392-index.htm |
| 2020-05-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1454789/000110465920060145/0001104659-20-060145-index.htm |
| 2020-06-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1454789/000110465920072654/0001104659-20-072654-index.htm |
| 2020-06-12 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1454789/000110465920072655/0001104659-20-072655-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000110465920072726/0001104659-20-072726-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000110465920072733/0001104659-20-072733-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000110465920072734/0001104659-20-072734-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000110465920072735/0001104659-20-072735-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000110465920072736/0001104659-20-072736-index.htm |
| 2020-06-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000110465920072740/0001104659-20-072740-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000110465920072742/0001104659-20-072742-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000110465920072749/0001104659-20-072749-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1454789/000110465920092697/0001104659-20-092697-index.htm |
| 2020-09-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1454789/000110465920106764/0001104659-20-106764-index.htm |
| 2020-09-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000110465920106765/0001104659-20-106765-index.htm |
| 2020-10-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1454789/000110465920118204/0001104659-20-118204-index.htm |
| 2018-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911018011280/0001179110-18-011280-index.htm |
| 2018-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911018011282/0001179110-18-011282-index.htm |
| 2018-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911018011283/0001179110-18-011283-index.htm |
| 2018-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911018011284/0001179110-18-011284-index.htm |
| 2019-01-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911019000342/0001179110-19-000342-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911019000343/0001179110-19-000343-index.htm |
| 2019-01-04 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911019000404/0001179110-19-000404-index.htm |
| 2019-02-15 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911019001937/0001179110-19-001937-index.htm |
| 2019-02-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911019001938/0001179110-19-001938-index.htm |
| 2019-02-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911019001939/0001179110-19-001939-index.htm |
| 2019-02-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911019001940/0001179110-19-001940-index.htm |
| 2019-02-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911019001941/0001179110-19-001941-index.htm |
| 2019-02-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911019001942/0001179110-19-001942-index.htm |
| 2019-02-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911019001943/0001179110-19-001943-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911019007182/0001179110-19-007182-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911019007183/0001179110-19-007183-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911019007184/0001179110-19-007184-index.htm |
| 2019-07-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911019008892/0001179110-19-008892-index.htm |
| 2019-07-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911019008893/0001179110-19-008893-index.htm |
| 2019-09-19 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911019010492/0001179110-19-010492-index.htm |
| 2019-09-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911019010493/0001179110-19-010493-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911020001597/0001179110-20-001597-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911020001598/0001179110-20-001598-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911020001600/0001179110-20-001600-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911020001601/0001179110-20-001601-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1454789/000117911020001613/0001179110-20-001613-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1454789/000119312519038264/0001193125-19-038264-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1454789/000119312520029762/0001193125-20-029762-index.htm |
| 2020-02-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1454789/000138713120001217/0001387131-20-001217-index.htm |
| 2018-07-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1454789/000162363218000855/0001623632-18-000855-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1454789/000162363219000243/0001623632-19-000243-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1454789/000162363220000259/0001623632-20-000259-index.htm |
| 2018-06-19 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1454789/999999999518001544/9999999995-18-001544-index.htm |
| 2019-05-22 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1454789/999999999519001170/9999999995-19-001170-index.htm |
| 2019-05-23 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1454789/999999999519001201/9999999995-19-001201-index.htm |